18 years of age and older

Histologically documented adenocarcinoma of prostate

Currently receiving LHRH agonists with castrate levels of testosterone or who have had an orchiectomy

Must have had a rise in PSA despite anti androgen withdrawal

Exhibit 2 consecutive rise in PSA after the last hormonal manipulation

Minimum PSA of greater than 5 KPS greater than 80%

Normal cortisol level at entry

Life expectancy greater than 6 months

Provide written consent pursuant to regulatory requirements prior to initiation of study procedure

A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer